Acri Capital Acquisition logo
Acri Capital Acquisition
ACAC | NASDAQ
Chart Builder DCF Calculator
$11.20
-$0.52 (-4.44%)
At close: Sep 26, 2024, 04:00 PM ET

Acri Capital Acquisition Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q2 2021
Jun 30, 2021
-245.3K 102.65K 158.9K 272.86K 90.95K 363.66K 233.12K 144.69K -159.94K -645 -7.04M
– – – – – – – – – – 12.93M
– – – – – – – – – – 2.93M
-227.78K -12.23K 248.75K 57.35K 198.5K -95.35K 319.69K -122.97K -49.7K – 8.04M
-354.97K -475.84K -478.9K -476.94K -456.42K -706.68K -690.4K -415.04K -49.7K – –
-15.39K 265 1.88K -1.57K 2.89K -29.86K 60.59 – – – -2.29M
-227.78K -12.23K 248.75K 57.35K 198.5K -95.35K 319.69K -122.97K -49.7K – 8.6M
-843.44K -385.16K -69.38K -148.3K -164.09K -468.23K -137.54K -393.32K -209.64K -645 15.14M
– – – – – – – – – – -491K
– – – – – – – – – – –
– – -225K -1.14M – – – – -87.98M – –
– – – 5.12M – – – – – – –
16.51M -225K -225K 3.98M -683.19K 51.52M – – -87.98M – -20.69M
16.51M -225K -225K 3.98M -683.19K 51.52M – – -87.98M – -21.18M
425.76K 645.82K 295.82K 225K 683.19K 227.73K – – -6.15K 6.15K –
-16.18M – 55.66M -4.21M – -51.46M – – – – –
– – – – – – – – – – –
– – – – – – – – -2.25M – 187.22M
-15.76M 645.82K 295.82K -3.98M 683.19K -51.23M – – 89.23M 31.15K 187.22M
-85.29K 35.67K 1.45K -148.3K -164.08K -182.25K -1.76M -393.32K 1.05M 30.51K -831.82M
-843.44K -385.16K -69.38K -148.3K -164.09K -468.23K -137.54K -393.32K -209.64K -645 14.65M
-843.44K -385.16K -69.38K -148.3K -164.09K -468.23K -137.54K -393.32K -209.64K -645 11.72M
– – – – – – – – – – -491K
– – – – – – – – – – –
-843.44K -385.16K -69.38K -148.3K -164.09K -468.23K -137.54K -393.32K -209.64K -645 14.65M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.